CHINA HEALTH GRP HD-10 - Asset Resilience Ratio

Latest as of June 2025: 1.54%

CHINA HEALTH GRP HD-10 (VNL1) has an Asset Resilience Ratio of 1.54% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€1.70 Million

≈ $1.98 Million USD Cash + Short-term Investments

Total Assets

€110.02 Million

≈ $128.62 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how CHINA HEALTH GRP HD-10's Asset Resilience Ratio has changed over time. See CHINA HEALTH GRP HD-10 (VNL1) flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down CHINA HEALTH GRP HD-10's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CHINA HEALTH GRP HD-10 (VNL1) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.70 Million	1.54%
Total Liquid Assets	€1.70 Million	1.54%

Asset Resilience Insights

Limited Liquidity: CHINA HEALTH GRP HD-10 maintains only 1.54% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CHINA HEALTH GRP HD-10 Industry Peers by Asset Resilience Ratio

Compare CHINA HEALTH GRP HD-10's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Veracyte Inc NASDAQ:VCYT	Diagnostics & Research	3.72%
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	Diagnostics & Research	0.14%
Microba Life Sciences Ltd AU:MAP	Diagnostics & Research	11.53%
Genetic Signatures Ltd AU:GSS	Diagnostics & Research	60.91%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Vijaya Diagnostic Centre Limited NSE:VIJAYA	Diagnostics & Research	16.55%
Cowealth Medical China Co.Ltd. SHG:603122	Diagnostics & Research	2.25%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%

Annual Asset Resilience Ratio for CHINA HEALTH GRP HD-10 (2021–2024)

The table below shows the annual Asset Resilience Ratio data for CHINA HEALTH GRP HD-10.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.68%	€1.70 Million ≈ $1.98 Million	€100.96 Million ≈ $118.03 Million	-0.97pp
2023-12-31	2.65%	€3.16 Million ≈ $3.70 Million	€119.35 Million ≈ $139.53 Million	-1.83pp
2022-12-31	4.48%	€8.01 Million ≈ $9.36 Million	€178.62 Million ≈ $208.83 Million	+1.57pp
2021-12-31	2.91%	€5.66 Million ≈ $6.62 Million	€194.32 Million ≈ $227.19 Million	--

pp = percentage points

About CHINA HEALTH GRP HD-10

F:VNL1 Germany Diagnostics & Research

Market Cap

$1.16 Million

€995.35K EUR

Market Cap Rank

#30485 Global

#2673 in Germany

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.03

All Time High

€0.07